Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9820264 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
Condition: Prostatic Hyperplasia
Interventions: Drug: BONT-A intra-prostatic injection;   Drug: Optimized medical BPH treatment

Study has passed its completion date and status has not been verified in more than two years.